Vancouver, BC (September 26, 2023) – WEX Pharmaceuticals Inc. (“WEX” or the “Company”), a clinicalstage biotechnology company developing Halneuron® (Tetrodotoxin or TTX) for pain, is pleased to announce the presentation of a scientific poster on Halneuron® at the 13th Congress of the European Pain Federation (EFIC®) in Budapest, Hungary on September 20th, 2023. This was one of the largest international congresses on pain in 2023.